Kantonsspital St.Gallen
login

A dose blind, multicenter, extension study to determine the safety and efficasy of 2 doses of BG00012 monotherapy with Relapsin Remitting Multiple Sclerosis

Stefanie Müller & Jochen Vehoff

abstract A dose blind, multicenter, extension study to determine the safety and efficasy of 2 doses of dimethyl fumarate (BG00012) monotherapy with Relapsin Remitting Multiple Sclerosis
   
type of project clinical studies
status ongoing - follow up
start of project 2010
end of project 2020
responsible person Stefanie Müller